Please use this identifier to cite or link to this item:
Title: What is the relevance of an ambulatory quick diagnosis unit or inpatient admission for the diagnosis of pancreatic cancer? A retrospective study of 1004 patients
Author: Bosch Aparici, Francisco Javier
Moreno, Pedro
Guerra García, Mar
Guasch, Neus
López-Soto, Alfonso
Keywords: Càncer de pàncrees
Atenció primària
Assistència hospitalària
Pancreas cancer
Primary care
Hospital care
Issue Date: 1-Mar-2020
Publisher: Lippincott, Williams & Wilkins. Wolters Kluwer Health
Abstract: Quick diagnosis units (QDU) have become an alternative hospital-based ambulatory medicine strategy to inpatient hospitalization for potentially serious illnesses in Spain. Whether diagnosis of pancreatic cancer is better accomplished by an ambulatory or inpatient approach is unknown. The main objective of this retrospective study was to examine and compare the diagnostic effectiveness of a QDU or inpatient setting in patients with pancreatic cancer. Patients with a diagnosis of pancreatic adenocarcinoma who had been referred to a university, tertiary hospital-based QDU or hospitalized between 2005 and 2018 were eligible. Presenting symptoms and signs, risk and prognostic factors, and time to diagnosis were compared. The costs incurred during the diagnostic assessment were analyzed with a microcosting method. A total of 1004 patients (508 QDU patients and 496 inpatients) were eligible. Admitted patients were more likely than QDU patients to have weight loss, asthenia, anorexia, abdominal pain, jaundice, and palpable hepatomegaly. Time to diagnosis of inpatients was similar to that of QDU patients (4.1 [0.8 vs 4.3 [0.6] days; P = .163). Inpatients were more likely than QDU patients to have a tumor on the head of the pancreas, a tumor size >2 cm, a more advanced nodal stage, and a poorer histological differentiation. No differences were observed in the proportion of metastatic and locally advanced disease and surgical resections. Microcosting revealed a cost of 347.76 (48.69) per QDU patient and 634.36 (80.56) per inpatient (P < .001). Diagnosis of pancreatic cancer is similarly achieved by an inpatient or QDU clinical approach, but the latter seems to be cost-effective. Because the high costs of hospitalization, an ambulatory diagnostic assessment may be preferable in these patients.
Note: Reproducció del document publicat a:
It is part of: Medicine, 2020, vol. 99, num. 11, p. e19009
Related resource:
ISSN: 0025-7974
Appears in Collections:Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
710344.pdf274.89 kBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons